You'll also benefit from the support of our clinical team
You may be a good candidate if: You are an adult with a BMI of 30 or higher, or You have a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, or heart disease
A higher-dose formulation of Semaglutide, marketed as Wegovy, has been FDA-approved for weight management in adults without diabetes, particularly those with obesity or related health risks
So when you remove the GLP-1 medication, that patient is set back on a course of weight increase. In other words, without the medication to block and promote pathways that can affect a bodys biochemistry, a person is more likely to return to consuming more calories and regaining weight
The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician